# First in Human Trial of CTX-187 in Healthy Volunteers and Chronically Infected Patients

> **NCT07708116** · PHASE1 · RECRUITING · sponsor: **Centauri Therapeutics Limited** · enrollment: 104 (estimated)

## Conditions studied

- Bronchiectasis Adult
- Bronchiectasis With Pseudomonas Aeruginosa Colonization
- Bacterial Infections

## Interventions

- **DRUG:** Placebo
- **DRUG:** CTX-187

## Key facts

- **NCT ID:** NCT07708116
- **Lead sponsor:** Centauri Therapeutics Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-16
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2026-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07708116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07708116, "First in Human Trial of CTX-187 in Healthy Volunteers and Chronically Infected Patients". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07708116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*